The acetylcholinesterase (AChE) inhibitor galantamine, approved for the treatment of cognitive symptoms of Alzheimer’s disease, reduced the number of cigarettes smoked in alcohol-dependent patients [124]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.